Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus.
about
Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cellsApotopes and the biliary specificity of primary biliary cirrhosisPathogenesis of systemic lupus erythematosusAnaemia in systemic lupus erythematosus: from pathophysiology to clinical assessmentSerum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosusLinks between complement deficiency and apoptosis.Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathwayPhosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancerClearance Deficiency and Cell Death Pathways: A Model for the Pathogenesis of SLESystemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical PathwayInflammatory etiopathogenesis of systemic lupus erythematosus: an updateMolecular characterisation of plasma membrane-derived vesiclesPathophysiology of cutaneous lupus erythematosusLinking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosusApoptotic cell clearance: basic biology and therapeutic potential.Toll-like receptors in systemic lupus erythematosus: potential targets for therapeutic interventionHow apoptotic cells aid in the removal of their own cold dead bodiesDiscovering Molecules That Regulate Efferocytosis Using Primary Human Macrophages and High Content ImagingHigh mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserineEmerging therapies for systemic lupus erythematosus--focus on targeting interferon-alphaCorrelation of circulating CD27high plasma cells and disease activity in systemic lupus erythematosusAnti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE)Apoptotic cell responses in the splenic marginal zone: a paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunityHMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrinMedium perfusion enables engineering of compact and contractile cardiac tissueApoptotic DNA degradation into oligonucleosomal fragments, but not apoptotic nuclear morphology, relies on a cytosolic pool of DFF40/CAD endonucleaseClearance of Dying Cells by Phagocytes: Mechanisms and Implications for Disease Pathogenesis.The role of nucleotides in apoptotic cell clearance: implications for disease pathogenesis.The pathogenesis, diagnosis and treatment of lupus nephritis.The -844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE.Characterization of recombinant human autoantibody fragments directed toward the autoantigenic U1-70K protein.The yins and yangs of ceramide.Pathogenesis of human systemic lupus erythematosus: recent advances.Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency.Monocyte Siglec-14 expression is upregulated in patients with systemic lupus erythematosus and correlates with lupus disease activity.The role of apoptosis proteins and complement components in the etiopathogenesis of systemic lupus erythematosus.Increased expression of Mer tyrosine kinase in circulating dendritic cells and monocytes of lupus patients: correlations with plasma interferon activity and steroid therapy.Resequencing the susceptibility gene, ITGAM, identifies two functionally deleterious rare variants in systemic lupus erythematosus cases.Distinct proteome pathology of circulating microparticles in systemic lupus erythematosusLow production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus.
P2860
Q24322831-83B1E77A-A799-4ADE-A3D3-B78F7DC95CB3Q24646460-F0AF9DB9-3C00-404D-8724-D7F8B9ED5F5DQ24672873-170170E8-FB76-4A4C-962C-4CF04962C8E3Q24675466-B773C9A1-2DD7-4D41-B0B4-27391BF89E92Q24793357-38F185ED-CA2D-4723-8088-348C24D86E31Q24805502-63B21A78-9B0E-4E27-AE5A-F7C11751F4CDQ26746697-E7E60F24-7EF2-4B61-9A8A-34B316998ECCQ26766332-ED94D0FF-248D-4518-924F-971335634615Q26767511-74AFBA0A-C142-4E3D-8177-E9AB9D7F4694Q26768534-41903F54-7043-41F3-B833-2EE82B6F6455Q26796413-0F599F44-76D9-487E-95B7-2D189ED55CE8Q26799753-C9C49A94-9C4D-48E2-A8C7-FB255863B255Q26800275-CCB39CF2-B93E-4C29-ABA5-246A0F637A89Q26822662-958484E0-1A84-448B-962C-121B474244BCQ26825935-6A37A5BD-7058-4116-B952-9E7B8FEB9457Q26865485-3EA74B05-602D-4EA7-B3D5-8558CAE0B5AEQ27026126-6E01A238-8DA2-422E-B868-2A6BC942E46BQ27334880-D200DBAB-5289-42E0-B9B2-FD1EBB21D48AQ28118997-054CA605-9B24-4E4F-A401-1AA9E07BB708Q28265144-53300AA6-0E8A-4F4A-B2F0-10D1C76BFEDAQ28269798-C900347F-2AA5-47C8-ADDC-4E66ACBB5A00Q28347243-F346993C-82CA-4699-ADD2-FCF7D3BD6E6CQ28385358-C4ACA0FD-7F1B-4AC6-B169-0736A1EA0D6CQ28506871-7C6F9DAB-4B43-470E-9BDF-6DE2CBDB215FQ28564386-9603C5CA-536F-4ADE-9684-8B22234733C0Q28910429-75D7A797-E877-4916-85C2-A99A49CC22A1Q30276066-1D21746D-1A07-4097-A9FA-FDC47881185BQ30429149-AF0721C5-93B8-4564-A0A0-2F31A1EA34AEQ30596968-18E886ED-D3FA-41BC-ABFF-0CC022B27423Q31143990-5E7C1B18-CD52-481A-9E2B-26D297EA3915Q31825208-2169E9BC-2407-4891-9F33-29E91F9D098BQ33632078-5FBC33D8-81CB-488C-9B46-A6BF1C899FDFQ33664927-113D60FA-BCC6-4841-8B39-6DC67ECEA6CAQ33683897-A8C7098E-6FD7-4293-81E8-3ADAAF9E2451Q33731305-D4BCA91F-9C7E-4F21-8125-4BF8CADE4022Q33754111-3D55CA51-8ABA-4EF0-9F96-BB9EC1288A2DQ33765614-21AA3FF8-402E-41D8-9435-BBAA63F399A1Q33766677-3C5D4470-1C7A-4D53-8743-32290E0E60B7Q33820385-F2E6548D-0EC4-4EC5-8DAB-36B47BC28323Q33821471-9A008D2A-B93B-4EBA-A4DE-9F622DD3FDDE
P2860
Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Impaired phagocytosis of apopt ...... systemic lupus erythematosus.
@en
Impaired phagocytosis of apopt ...... systemic lupus erythematosus.
@nl
type
label
Impaired phagocytosis of apopt ...... systemic lupus erythematosus.
@en
Impaired phagocytosis of apopt ...... systemic lupus erythematosus.
@nl
prefLabel
Impaired phagocytosis of apopt ...... systemic lupus erythematosus.
@en
Impaired phagocytosis of apopt ...... systemic lupus erythematosus.
@nl
P2093
P2860
P921
P1476
Impaired phagocytosis of apopt ...... systemic lupus erythematosus.
@en
P2093
P2860
P304
P356
10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H
P577
1998-07-01T00:00:00Z